The Magee 3 Equation Predicts Favorable Pathologic Response to Neoadjuvant Endocrine Therapy in Breast Cancer Patients.

Carlos Eduardo PaivaMaria Paola Montesso ZontaRafaela Carvalho GraneroVitor Souza GuimarãesLayla Melo PimentaGustavo Ramos TeixeiraBianca Sakamoto Ribeiro Paiva

Published in: Cancers (2024)

Patients with ME3 < 20 have a higher likelihood of presenting a pathological response, offering a cost-effective alternative tool to Oncotype DX. Larger future studies with a prospective design are awaited to confirm our findings.

Keyphrases

locally advanced
rectal cancer
neoadjuvant chemotherapy
lymph node
current status
case control
case report
radiation therapy
stem cells
replacement therapy